A Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP): Statistical analysis plan [version 1; peer review: 2 approved]

Harding, R; Ataide, R; Mwangi, MN; Simpson, JA; Mzembe, G; Moya, E; Truwah, Z; Nkhwazi, BC; Mwabinga, M; Nkhono, W; Phiri, KS; Pasricha, SR; Braat, S

Author(s): Harding, R; Ataide, R; Mwangi, MN; Simpson, JA; Mzembe, G; Moya, E; Truwah, Z; Nkhwazi, BC; Mwabinga, M; Nkhono, W; Phiri, KS; Pasricha, SR; Braat, S;
Details: Publication Year 2021,Volume 5,Issue #174,Page https://gatesopenresearch.org/articles/5-174/v1
Journal Title: Gates Open Research
Abstract: Background: Anaemia affects more than half of Africa’s pregnancies. Standard care, with oral iron tablets, often fails to achieve results, with compliance and gastrointestinal side-effects being a significant issue. In recent years, intravenous iron formulations have become safe, effective, and quick to administer, allowing the complete iron requirements of pregnancy to be provided in one 15-minute infusion. The Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP) will evaluate whether a modern intravenous iron formulation, ferric carboxymaltose (FCM), given once during the second trimester is effective and safe in improving maternal and neonatal outcomes for treatment of moderate to severe anaemia in sub-Saharan Africa. ; The objective was to publish the detailed statistical analysis plan for the REVAMP trial prior to unblinding the allocated treatments and performing the analysis. ; Methods: REVAMP is a multicentre, two-arm, open-label, parallel-group randomized control trial (RCT) in 862 pregnant women in their second trimester. The trial statistician developed the statistical analysis plan in consultation with the trial management team based on the protocol, data collection forms, and study outcomes available in the blinded study database. ; Results: The detailed statistical analysis plan will support the statistical analyses and reporting of the REVAMP trial after unblinding the treatment allocations. ; Conclusions: A statistical analysis plan allows for transparency as well as reproducibility of reporting and statistical analyses
Publisher: F1000
Keywords: anaemia, iron deficiency, intravenous iron, ferric carboxymaltose (FCM), pregnancy, randomized controlled trial, statistical analysis, Malawi
Research Division(s): Population Health And Immunity
Publisher's Version: https://doi.org/10.12688/gatesopenres.13457.1
Open Access at Publisher's Site: https://doi.org/10.12688/gatesopenres.13457.1
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2022-02-07 10:12:15

Last Modified: 2022-02-08 11:36:26